Frankfurt, 7th November 2018.The ORPEA group, a world leader in long-term care (nursing homes, post-acute and rehabilitation hospitals, psychiatric hospitals, and homecare services), announced the acquisition of Axion group in Germany.
ACXIT Capital Partners, represented by Thomas Klack and his team, acted as exclusive financial advisor to ORPEA in this transaction. The parties agreed not to disclose any details of the transaction.
Frankfurt, 6th November 2018. The publicly traded French Software as a Service (SaaS) company Oxatis is taking over Channel Pilot Solutions GmbH, with its product data management tool, to further extend its technological lead and accelerate growth in Europe. ACXIT Capital Partners (in cooperation with PAX Corporate Finance) acted as the exclusive M&A advisor to Channel Pilot Solutions GmbH and its shareholders.
London, 28 November 2018.ACXIT’s partner FirstCapital advised on the completion of a secondary management buyout funded by Ethos Partners and Santander, ensuring new backing for Miles 33’s next phase of growth.
Munich, 29th October 2018. Attorney Rolf G. Pohlmann was able to sell Genomatix AG to a listed market leader within the biotech industry from outside Europe in the course of a transferred restructuring.
Frankfurt, 26th October 2018. ACXIT Capital Partners exclusively advises casualfood GmbH (“casualfood”), one of Germany’s leading operators of innovative travel catering concepts, and its shareholders on the strategic partnership with Swiss food and beverage group ORIOR AG (“ORIOR”).
Link between mail-order activities of medpex and Zur Rose subsidiary DocMorris
Additional growth opportunities due to outstandingly complementary activities
The founders and managers of medpex will continue to lead the activities and will become shareholders in the Zur Rose Group AG
Frankfurt, 18 October 2018. medpex, the third biggest online pharmacy in Germany, is bundling its activities with Swiss company Zur Rose Group AG. With this step, medpex is setting the basis to continue its successful growth trajectory at a high pace in the future and play a proactive role in market consolidation. The outstandingly complementary activities of medpex and Zur Rose subsidiary DocMorris create additional growth opportunities for both companies. Customers will benefit from an even broader product range and from additional services. The founders and managers of medpex will also become shareholders in Zur Rose Group AG as part of the transaction.
Frankfurt, 04 October 2018. ACXIT Capital Partners, one of the leading corporate finance and investment advisory firms in Europe, is pleased to announce the addition of senior industry advisor Michael Brecht to its newly established next-gen mobility practice. He is one of the bespoken industry experts in next generation mobility topics with special focus on smart mobility, e-mobility, startup financing and strategic growth.
Frankfurt, 03 August 2018. ACXIT Capital Partners exclusively advised Wickeder Westfalenstahl GmbH, one of the world’s leading manufacturers of clad flat products, on the Management Buy-Out (MBO) of Deutsche Nickel Group.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.